Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Horizon Pharma, Inc. (HZNP)  
$28.30 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 211,410,000
Market Cap: 5.98(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $28.3 - $28.3
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Horizon Therapeutics is focused on researching, developing and commercializing medicines that address the needs for people with rare and rheumatic diseases. Co. has two segments, the orphan segment and the inflammation segment. The Orphan segment includes: TEPEZZA, which is indicated for the treatment of thyroid eye diseas; KRYSTEXXA, which is indicated for the treatment of uncontrolled gout; and PROCYSBI, which is indicated for nephropathic cystinosis. The Inflammation segment includes: PENNSAID 2% w/w, which is indicated for the treatment of pain of osteoarthritis (OA), of the knee(s); and DUEXIS, which is indicated for the relief of signs and symptoms of rheumatoid arthritis and OA.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 745
Total Buy Value $0 $0 $0 $49,669
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 0 0 140,235
Total Sell Value $0 $0 $0 $15,458,802
Total People Sold 0 0 0 4
Total Sell Transactions 0 0 0 11
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 961
  Page 22 of 39  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Konstantinovsky Irina EVP, Chief Human Resources Off   •       –      –    2020-01-21 4/A D $38.25 $67,779 D/D (1,772) 49,577     -
   Konstantinovsky Irina EVP, Chief Human Resources Off   •       –      –    2020-01-21 4/A A $0.00 $0 D/D 3,998 51,349     -
   Beeler Brian K EVP, General Counsel   •       –      –    2020-01-21 4/A D $38.25 $69,806 D/D (1,825) 107,055     -
   Beeler Brian K EVP, General Counsel   •       –      –    2020-01-21 4/A A $0.00 $0 D/D 4,119 108,880     -
   Desjardin Michael A. EVP, Technical Operations   •       –      –    2020-01-21 4/A D $38.25 $69,768 D/D (1,824) 61,882     -
   Desjardin Michael A. EVP, Technical Operations   •       –      –    2020-01-21 4/A A $0.00 $0 D/D 3,678 63,706     -
   Kent Jeff See remarks   •       –      –    2020-01-07 4 AS $36.50 $129,393 D/D (3,545) 111,667     -
   Karnani Vikram EVP, Chief Commercial Officer   •       –      –    2020-01-06 4 AS $35.62 $331,159 D/D (9,297) 78,146     -
   Walbert Timothy P Chairman, President and CEO   •       •      –    2020-01-06 4 AS $35.57 $3,019,395 D/D (84,886) 903,309     -
   Hoelscher Paul W. EVP, CFO   •       –      –    2020-01-05 4 D $36.10 $2,502,488 D/D (69,321) 226,043     -
   Hoelscher Paul W. EVP, CFO   •       –      –    2020-01-05 4 A $0.00 $0 D/D 72,376 295,364     -
   Hoelscher Paul W. EVP, CFO   •       –      –    2020-01-05 4 OE $0.00 $0 D/D 83,678 222,988     -
   Beeler Brian K EVP, General Counsel   •       –      –    2020-01-05 4 D $36.10 $783,009 D/D (21,690) 104,761     -
   Beeler Brian K EVP, General Counsel   •       –      –    2020-01-05 4 A $0.00 $0 D/D 19,014 126,451     -
   Beeler Brian K EVP, General Counsel   •       –      –    2020-01-05 4 OE $0.00 $0 D/D 29,520 107,437     -
   Lin Shao-Lee EVP, Head of R&D and CSO   •       –      –    2020-01-05 4 D $36.10 $1,375,410 D/D (38,100) 106,255     -
   Lin Shao-Lee EVP, Head of R&D and CSO   •       –      –    2020-01-05 4 A $0.00 $0 D/D 35,652 144,355     -
   Lin Shao-Lee EVP, Head of R&D and CSO   •       –      –    2020-01-05 4 OE $0.00 $0 D/D 50,344 108,703     -
   Konstantinovsky Irina EVP, Chief Human Resources Off   •       –      –    2020-01-05 4 D $36.10 $783,009 D/D (21,690) 47,351     -
   Konstantinovsky Irina EVP, Chief Human Resources Off   •       –      –    2020-01-05 4 A $0.00 $0 D/D 19,014 69,041     -
   Konstantinovsky Irina EVP, Chief Human Resources Off   •       –      –    2020-01-05 4 OE $0.00 $0 D/D 29,520 50,027     -
   Karnani Vikram EVP, Chief Commercial Officer   •       –      –    2020-01-05 4 D $36.10 $874,523 D/D (24,225) 87,443     -
   Karnani Vikram EVP, Chief Commercial Officer   •       –      –    2020-01-05 4 A $0.00 $0 D/D 19,014 111,668     -
   Karnani Vikram EVP, Chief Commercial Officer   •       –      –    2020-01-05 4 OE $0.00 $0 D/D 35,242 92,654     -
   Curtis Geoffrey M. EVP, Corporate Affairs, CCO   •       –      –    2020-01-05 4 D $36.10 $487,964 D/D (13,517) 54,680     -

  961 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 22 of 39
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed